Small Drugs, Huge Impact: The Extraordinary Impact of Antisense Oligonucleotides in Research and Drug Development
Antisense oligonucleotides (ASOs) are an increasingly represented class of drugs. These small sequences of nucleotides are designed to precisely target other oligonucleotides, usually RNA species, and are modified to protect them from degradation by nucleases. Their specificity is due to their seque...
Main Authors: | Anais M. Quemener, Maria Laura Centomo, Scott L. Sax, Riccardo Panella |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/2/536 |
Similar Items
-
Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
by: Clarice Gareri, et al.
Published: (2022-07-01) -
Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome
by: Dongwon Lee, et al.
Published: (2023-01-01) -
Making Sense of Antisense Oligonucleotide Therapeutics Targeting Bcl-2
by: Maria Gagliardi, et al.
Published: (2022-01-01) -
Antisense oligonucleotides targeting ORF1b block replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
by: Sophie Dhorne-Pollet, et al.
Published: (2022-10-01) -
Structure-activity relationship study of mesyl and busyl phosphoramidate antisense oligonucleotides for unaided and PSMA-mediated uptake into prostate cancer cells
by: O. Sergeeva, et al.
Published: (2024-03-01)